HomeOXBDF • OTCMKTS
add
Oxford BioMedica plc
Previous close
$5.20
Year range
$2.09 - $5.68
Market cap
449.64M GBP
Avg Volume
692.00
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 25.40M | 17.99% |
Operating expense | 24.35M | -33.45% |
Net income | -16.24M | 32.26% |
Net profit margin | -63.94 | 42.59% |
Earnings per share | — | — |
EBITDA | -11.12M | 38.86% |
Effective tax rate | -1.86% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.41M | -37.10% |
Total assets | 244.97M | -38.92% |
Total liabilities | 173.75M | -14.37% |
Total equity | 71.22M | — |
Shares outstanding | 105.30M | — |
Price to book | 8.25 | — |
Return on assets | -15.68% | — |
Return on capital | -21.16% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -16.24M | 32.26% |
Cash from operations | -19.60M | -624.03% |
Cash from investing | 3.64M | 308.64% |
Cash from financing | 4.89M | 241.93% |
Net change in cash | -11.15M | -88.17% |
Free cash flow | -7.49M | 34.31% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Founded
1995
Website
Employees
834
